EUVIMEDEUVIMED entdecken
Crossref

Hepatitis C virus core antigen: A diagnostic and treatment monitoring marker of hepatitis C virus in Indian population

Jaya Garg iD, Prashant Verma, Mridu Singh, Anupam Das, Anurag Pathak, Jyotsna Agarwal

Indian Journal of Gastroenterology · 2024

DOI: 10.1007/s12664-024-01549-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Gastroenterology, 2024. Verfasst von Jaya Garg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, 226 010, India. jaya_bhu@rediffmail.com. Hauptthemen laut MEDLINE: Hepatitis C, Hepacivirus, Hepatitis C Antigens, Biomarkers. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The diagnosis and treatment monitoring of hepatitis C is quite challenging. The screening test, i.e. antibody assay, is unable to detect acute cases, while the gold standard hepatitis C virus (HCV) reverse transcriptase polymerase chain reaction (RTPCR) assay is not feasible in resource-limited countries such as India due to high cost and infrastructure requirement. European Association for the Study of the Liver and World Health Organization have approved a new marker, i.e. HCV core antigen (HCVcAg) assay, as an alternative to molecular assay. In this study, we have evaluated HCVcAg assay for diagnosis and treatment monitoring follow-up in Indian population infected with hepatitis C. METHODS: Blood specimen of 90 clinically suspected cases of acute hepatitis C were tested simultaneously for anti-HCV antibody assay via ELISA (enzyme-linked immunoassay), HCVcAg assay by chemiluminescence immune assay (CLIA) and HCV RTPCR VL (viral load) assay. Thirty-four HCV RTPCR positive patients were further enrolled in treatment monitoring group whose blood samples were tested at the beginning of treatment, two weeks, four weeks and 12 weeks via HCV core Ag assay and HCV RTPCR Viral Load assay. RESULTS: Considering HCV RTPCR as gold standard, diagnostic performance of HCV core Ag assay and anti-HCV antibody assay was evaluated. The sensitivity and specificity of HCV core Ag assay were higher than that of anti-HCV Antibody assay, i.e. 88.3% and 100% vs. 23.3% and 83.3%, respectively. The overall diagnostic accuracy of HCV core Ag assay was 92.20%. Among treatment follow-up group, HCV core Ag levels correlated well with HCV viral load levels, at the beginning of treatment (baseline) till 12 weeks showing highly significant Spearman rank correlation coefficient of > 0.9 with HCV viral load levels. CONCLUSIONS: HCV core Ag assay is a cost-effective, practically feasible substitute of HCV RTPCR viral load assay for diagnosis as well as long duration treatment monitoring of hepatitis C infection in resource-limited settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CHepacivirusHepatitis C AntigensBiomarkersViral LoadHumansIndiaMaleFemaleAntiviral AgentsSensitivity and SpecificityHepatitis C AntibodiesAdultViral Core ProteinsMiddle AgedEnzyme-Linked Immunosorbent AssayReverse Transcriptase Polymerase Chain Reaction

Stichwörter der Autor:innen

Antibody assayAntiviralCLIACorrelation coefficientCost effectiveDiagnostic algorithmELISAEliminationFollow-upQuantitativeRTPCRResource limitedScreeningViral load assay

Substanzen

Hepatitis C AntigensBiomarkersAntiviral AgentsHepatitis C AntibodiesViral Core Proteins

Autor:innen und Institutionen

  • Department of Microbiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, 226 010, India. jaya_bhu@rediffmail.com.
  • Department of Gastromedicine, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, 226 010, India.
  • Department of Medicine, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, 226 010, India.
  • Department of Microbiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, 226 010, India.
  • Department of Community Medicine, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, 226 010, India.

ORCID-Profile: Jaya Garg

Zitieren

APA

Garg, J., Verma, P., Singh, M., Das, A., Pathak, A., & Agarwal, J. (2024). Hepatitis C virus core antigen: A diagnostic and treatment monitoring marker of hepatitis C virus in Indian population. Indian Journal of Gastroenterology. https://doi.org/10.1007/s12664-024-01549-7

Vancouver

Garg J, Verma P, Singh M, Das A, Pathak A, Agarwal J. Hepatitis C virus core antigen: A diagnostic and treatment monitoring marker of hepatitis C virus in Indian population. Indian Journal of Gastroenterology. 2024. doi:10.1007/s12664-024-01549-7

BibTeX
@article{Garg2024,
  author = {Garg, Jaya and Verma, Prashant and Singh, Mridu and Das, Anupam and Pathak, Anurag and Agarwal, Jyotsna},
  title = {Hepatitis C virus core antigen: A diagnostic and treatment monitoring marker of hepatitis C virus in Indian population},
  journal = {Indian Journal of Gastroenterology},
  year = {2024},
  doi = {10.1007/s12664-024-01549-7}
}
Kostenlos starten →